𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Consequences of parental exposure to epidermal growth factor for progeny cell division

✍ Scribed by John K. Heath

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
394 KB
Volume
115
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Responses of Preneoplastic Epidermal Cel
Responses of Preneoplastic Epidermal Cells to Tumor Promoters and Growth Factors: Use of Promoter-Resistant Variants for Mechanism Studies
✍ Nancy H. Colburn; Edmund Wendel; Leela Srinivas 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

## Abstract The JB6 mouse epidermal cell model system is being used to study the mechanism of promotion of transformation. Promotion of anchorage independence in JB6 cells occurs in response to second‐stage but not first‐stage promoters, and is inhibited by inhibitors of second‐stage not first‐stag

Comparison of fixation protocols for adh
Comparison of fixation protocols for adherent cultured cells applied to a GFP fusion protein of the epidermal growth factor receptor
✍ Roland Brock; Irene H.L. Hamelers; Thomas M. Jovin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

## Background: The analysis of the subcellular distribution of proteins is essential for the understanding of processes such as signal transduction. in most cases, the parallel analysis of multiple components requires fixation and immunofluorescence labeling. therefore, one has to ascertain that th

Detection of epidermal growth factor rec
Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer
✍ Chen He; Ming Liu; Chengzhi Zhou; Jiexia Zhang; Ming Ouyang; Nanshan Zhong; Jun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 260 KB 👁 2 views

## Abstract The high frequency of epidermal growth factor receptor (__EGFR__) mutations in tyrosine kinase inhibitor‐responsive non‐small‐cell lung cancer (NSCLC) cases is now well established, highlighting the predictive value of activating __EGFR__ mutations in guiding the clinical use of __EGFR_